Safety and Effectiveness of Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide) in Patients with HIV-1 Infection: Interim Report of a Post-Marketing Surveillance Study in Korea.

Saved in:
Bibliographic Details
Title: Safety and Effectiveness of Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide) in Patients with HIV-1 Infection: Interim Report of a Post-Marketing Surveillance Study in Korea.
Authors: Kim, Shin-Woo1, Peters, Jami2, Lang, Markus G.2, Lee, Jeong-a3, Cha, Jinhye3, Kim, Yeon-Sook4 alice@cnuh.co.kr
Source: Infection & Chemotherapy. Mar2026, Vol. 58 Issue 1, p122-127. 6p.
Database: Academic Search Ultimate
Description
ISSN:20932340
DOI:10.3947/ic.2025.0140